Is Vasomotion in Cerebral Arteries Impaired in Alzheimer’s Disease?
Open accessThe DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Abstract
A substantial body of evidence supports the hypothesis of a vascular component in the pathogenesis of Alzheimer's disease (AD). Cerebral hypoperfusion and blood-brain barrier dysfunction have been indicated as key elements of this pathway. Cerebral amyloid angiopathy (CAA) is a cerebrovascular disorder, frequent in AD, characterized by the accumulation of amyloid-β (Aβ) peptide in cerebral blood vessel walls. CAA is associated with loss of vascular integrity, resulting in impaired regulation of cerebral circulation, and increased susceptibility to cerebral ischemia, microhemorrhages, and white matter damage. Vasomotion- the spontaneous rhythmic modulation of arterial diameter, typically observed in arteries/arterioles in various vascular beds including the brain- is thought to participate in tissue perfusion and oxygen delivery regulation. Vasomotion is impaired in adverse conditions such as hypoperfusion and hypoxia. The perivascular and glymphatic pathways of Aβ clearance are thought to be driven by the systolic pulse. Vasomotion produces diameter changes of comparable amplitude, however at lower rates, and could contribute to these mechanisms of Aβ clearance. In spite of potential clinical interest, studies addressing cerebral vasomotion in the context of AD/CAA are limited. This study reviews the current literature on vasomotion, and hypothesizes potential paths implicating impaired cerebral vasomotion in AD/CAA. Aβ and oxidative stress cause vascular tone dysregulation through direct effects on vascular cells, and indirect effects mediated by impaired neurovascular coupling. Vascular tone dysregulation is further aggravated by cholinergic deficit and results in depressed cerebrovascular reactivity and (possibly) impaired vasomotion, aggravating regional hypoperfusion and promoting further Aβ and oxidative stress accumulation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Iliff, J. J., Wang, M., Liao, Y., Plogg, B. A., Peng, W., Gundersen, G. A., Benveniste, H., Vates, G. E., Deane, R., Goldman, S. A., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003748 · Cited by 5,824
Hearing loss and cognitive decline in older adults
Lin, F. R., Yaffe, K., Xia, J., Xue, Q.-L., Harris, T. B., Purchase-Helzner, E., Satterfield, S., Ayonayon, H. N., Ferrucci, L., Simonsick, E. M., et al. (2013) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.1868 · Cited by 4,017
Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation
Dimmeler, S., Fleming, I., Fisslthaler, B., Hermann, C., Busse, R., & Zeiher, A. M. (1999) · Nature · doi:10.1038/21224 · Cited by 3,591 · cited 2×
“stress [149] caused by disturbed blood flow [146–148].”
BackgroundNeurovascular pathways to neurodegeneration in Alzheimer’s disease and other disorders
Zlokovic, B. V. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn3114 · Cited by 2,969
Glial and neuronal control of brain blood flow
Attwell, D., Buchan, A. M., Charpak, S., Lauritzen, M., MacVicar, B. A., & Newman, E. A. (2010) · Nature · doi:10.1038/nature09613 · Cited by 2,511
Chiu, J.-J., & Chien, S. (2011) · Physiological Reviews · doi:10.1152/physrev.00047.2009 · Cited by 2,280
Neurovascular regulation in the normal brain and in Alzheimer's disease
Iadecola, C. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1387 · Cited by 2,213
Prevalence of Dementia in the United States: The Aging, Demographics, and Memory Study
Plassman, B. L., Langa, K. M., Fisher, G. G., Heeringa, S. G., Weir, D. R., Ofstedal, M. B., Burke, J. R., Hurd, M. D., Potter, G. G., Rodgers, W. L., et al. (2007) · Neuroepidemiology · doi:10.1159/000109998 · Cited by 1,932 · cited 1×
“Alzheimer’s disease (AD) is the most prevalent cause of dementia in the older population accounting for 65–70% of the cases [18–20].”
BackgroundCerebral Arterial Pulsation Drives Paravascular CSF–Interstitial Fluid Exchange in the Murine Brain
Iliff, J. J., Wang, M., Zeppenfeld, D. M., Venkataraman, A., Plog, B. A., Liao, Y., Deane, R., & Nedergaard, M. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.1592-13.2013 · Cited by 1,319 · cited 1×
“Observations using in vivo two-photon imaging suggest that the cerebrospinal fluid from the subarachnoid space enters the brain parenchyma following para-arterial influx routes in the Virchow-Robin space surrounding the penetrating cerebral arteries [75, 76].”
BackgroundDiabetes mellitus and risk of Alzheimer disease and decline in cognitive function
Arvanitakis, Z., Wilson, R. S., Bienias, J. L., Evans, D. A., & Bennett, D. A. (2004) · Archives of Neurology · doi:10.1001/archneur.61.5.661 · Cited by 1,258
Manczak, M., Anekonda, T. S., Henson, E., Park, B. S., Quinn, J., & Reddy, P. H. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl066 · Cited by 1,104 · cited 2×
“This in turn causes mitochondrial dysfunction [141, 217–220] in a detrimental vicious circle.”
BackgroundCerebral microvascular pathology in aging and Alzheimer's disease
Farkas, E., & Luiten, P. G. M. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(00)00068-x · Cited by 1,102
Self-citationMidlife and Late-Life Obesity and the Risk of Dementia: Cardiovascular Health Study
Fitzpatrick, A. L., Kuller, L. H., Lopez, O. L., Diehr, P., O’Meara, E. S., Longstreth, W. T., & Luchsinger, J. A. (2009) · Archives of Neurology · doi:10.1001/archneurol.2008.582 · Cited by 796
Review: Cerebral microvascular pathology in ageing and neurodegeneration
Brown, W. R., & Thore, C. R. (2011) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2010.01139.x · Cited by 749 · cited 18×
“Evaluation of cerebrovascular reactivity in AD by SPECT Imaging of regional CBF with SPECT has been used in the quantitative assessment of cerebrovascular deficits [154] in various conditions including AD [41–44, 176–180].”
BackgroundInfluentialCirrito, J. R. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25247 · Cited by 660 · cited 1×
“Of note, the latter include A transporters which are responsible for A clearance from the brain parenchyma [210, 211], in particular multidrug resistance-associated protein 1 (ABCC1) [212, 213] and ABC subfamily B member 1 (ABCB1) [214–216].”
BackgroundCerebral amyloid angiopathy in the elderly
Viswanathan, A., & Greenberg, S. M. (2011) · Annals of Neurology · doi:10.1002/ana.22516 · Cited by 643
van Beek, A. H., Claassen, J. A., Rikkert, M. G. O., & Jansen, R. W. (2008) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2008.13 · Cited by 485 · cited 1×
“[32–34], increasing neuronal vulnerability to hypoxia”
Grammas, P. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-26 · Cited by 432 · cited 1×
“endothelial cells exposed to A 1-40 [135].”
SOD1 rescues cerebral endothelial dysfunction in mice overexpressing amyloid precursor protein
Iadecola, C., Zhang, F., Niwa, K., Eckman, C., Turner, S. K., Fischer, E., Younkin, S., Borchelt, D. R., Hsiao, K. K., & Carlson, G. A. (1999) · Nature Neuroscience · doi:10.1038/5715 · Cited by 399
Cerebral amyloid angiopathy and its relationship to Alzheimer’s disease
Thal, D. R., Griffin, W. S. T., de Vos, R. A. I., & Ghebremedhin, E. (2008) · Acta Neuropathologica · doi:10.1007/s00401-008-0366-2 · Cited by 372
Review: sporadic cerebral amyloid angiopathy
Attems, J., Jellinger, K., Thal, D. R., & Van Nostrand, W. (2011) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2010.01137.x · Cited by 371 · cited 3×
“In the latter case, vasoconstriction could result in hypoperfusion downstream of the narrowing of the vascular lumen [126].”
BackgroundAbramov, A. Y., Canevari, L., & Duchen, M. R. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-12-05088.2003 · Cited by 337
Copper-Dependent Inhibition of Human Cytochrome c Oxidase by a Dimeric Conformer of Amyloid-β1-42
Crouch, P. J., Blake, R., Duce, J. A., Ciccotosto, G. D., Li, Q.-X., Barnham, K. J., Curtain, C. C., Cherny, R. A., Cappai, R., Dyrks, T., et al. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.4276-04.2005 · Cited by 327
Blood–brain barrier P-glycoprotein function in Alzheimer's disease
van Assema, D. M. E., Lubberink, M., Bauer, M., van der Flier, W. M., Schuit, R. C., Windhorst, A. D., Comans, E. F. I., Hoetjes, N. J., Tolboom, N., Langer, O., et al. (2012) · Brain · doi:10.1093/brain/awr298 · Cited by 318
Brain microbleeds and Alzheimer’s disease: innocent observation or key player?
Cordonnier, C., & van der Flier, W. M. (2011) · Brain · doi:10.1093/brain/awq321 · Cited by 310
Mechanisms to explain the reverse perivascular transport of solutes out of the brain
Schley, D., Carare-Nnadi, R., Please, C. P., Perry, V. H., & Weller, R. O. (2006) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2005.07.005 · Cited by 293
Müller, W. E., Eckert, A., Kurz, C., Eckert, G. P., & Leuner, K. (2010) · Molecular Neurobiology · doi:10.1007/s12035-010-8141-5 · Cited by 243
Abramov, A. Y., Canevari, L., & Duchen, M. R. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2004.09.006 · Cited by 223
Cerebral Hemodynamics and Vascular Risk Factors: Setting the Stage for Alzheimer's Disease
de la Torre, J. C. (2012) · Journal of Alzheimer's Disease · doi:10.3233/jad-2012-120793 · Cited by 219
Morris, M. C., Scherr, P. A., Hebert, L. E., Glynn, R. J., Bennett, D. A., & Evans, D. A. (2001) · Archives of Neurology · doi:10.1001/archneur.58.10.1640 · Cited by 217
Zhang, F., Eckman, C., Younkin, S., Hsiao, K. K., & Iadecola, C. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-20-07655.1997 · Cited by 205 · cited 1×
“In the former case, which is also supported by transgenic mouse studies [130], vessel dilation could reduce the vascular reactivity to vasodilatory stimuli such as ischemia [126, 132] or hypercapnia [133] (see section on cerebrovascular reactivity).”
BackgroundOverweight in midlife and risk of dementia: a 40-year follow-up study
Hassing, L. B., Dahl, A. K., Thorvaldsson, V, Berg, S., Gatz, M., Pedersen, N. L., & Johansson, B. (2009) · International Journal of Obesity · doi:10.1038/ijo.2009.104 · Cited by 197
Amyloid efflux transporter expression at the blood-brain barrier declines in normal aging
Silverberg, G. D., Messier, A. A., Miller, M. C., Machan, J. T., Majmudar, S. S., Stopa, E. G., Donahue, J. E., & Johanson, C. E. (2010) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181f46e25 · Cited by 191 · cited 1×
“Of note, the latter include A transporters which are responsible for A clearance from the brain parenchyma [210, 211], in particular multidrug resistance-associated protein 1 (ABCC1) [212, 213] and ABC subfamily B member 1 (ABCB1) [214–216].”
BackgroundPhotolysis of Caged Calcium in Femtoliter Volumes Using Two-Photon Excitation
Brown, E. B., Shear, J. B., Adams, S. R., Tsien, R. Y., & Webb, W. W. (1999) · Biophysical Journal · doi:10.1016/s0006-3495(99)77217-6 · Cited by 181
Vascular Risk Factors and Dementia: 40-Year Follow-Up of a Population-Based Cohort
Rönnemaa, E., Zethelius, B., Lannfelt, L., & Kilander, L. (2011) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000330020 · Cited by 171
Amyloid beta deregulates astroglial mGluR5‐mediated calcium signaling via calcineurin and Nf‐kB
Lim, D., Iyer, A., Ronco, V., Grolla, A. A., Canonico, P. L., Aronica, E., & Genazzani, A. A. (2013) · Glia · doi:10.1002/glia.22502 · Cited by 169
Han, B. H., Zhou, M.-L., Abousaleh, F., Brendza, R. P., Dietrich, H. H., Koenigsknecht-Talboo, J., Cirrito, J. R., Milner, E., Holtzman, D. M., & Zipfel, G. J. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.4686-08.2008 · Cited by 138
Aliev, G., Priyadarshini, M., Reddy, V., Grieg, N. H., Kaminsky, Y., Cacabelos, R., Ashraf, G., Jabir, N. R., Kamal, M. A., Nikolenko, V. N., et al. (2014) · Current Medicinal Chemistry · doi:10.2174/0929867321666131227161303 · Cited by 138
Paris, D., Humphrey, J., Quadros, A., Patel, N., Crescentini, R., Crawford, F., & Mullan, M. (2003) · Neurological Research · doi:10.1179/016164103101201940 · Cited by 127
Severe carotid stenosis and impaired cerebral hemodynamics can influence cognitive deterioration
Balestrini, S., Perozzi, C., Altamura, C., Vernieri, F., Luzzi, S., Bartolini, M., Provinciali, L., & Silvestrini, M. (2013) · Neurology · doi:10.1212/wnl.0b013e318295d71a · Cited by 126 · cited 1×
“Hypercapnic stimuli such as breath holding [155],”
Endothelin-1 is Elevated in Alzheimer's Disease and Upregulated by Amyloid-β
Palmer, J. C., Barker, R., Kehoe, P. G., & Love, S. (2012) · Journal of Alzheimer's Disease · doi:10.3233/jad-2012-111760 · Cited by 110 · cited 3×
“Endothelin-1 (ET-1) is a potent vasoconstrictor produced predominantly by vascular endothelial cells [186].”
BackgroundVasomotion and flowmotion: physiological mechanisms and clinical evidence
Intaglietta, M. (1990) · Vascular Medicine Review · doi:10.1177/1358836x9000100202 · Cited by 99
Altered cerebral hemodynamics in early Alzheimer disease: a pilot study using transcranial Doppler
Claassen, J. A. H. R., Diaz-Arrastia, R., Martin-Cook, K., Levine, B. D., & Zhang, R. (2009) · Journal of Alzheimer's Disease · doi:10.3233/jad-2009-1079 · Cited by 95
Li, H., Guo, Q., Inoue, T., Polito, V. A., Tabuchi, K., Hammer, R. E., Pautler, R. G., Taffet, G. E., & Zheng, H. (2014) · Molecular Neurodegeneration · doi:10.1186/1750-1326-9-28 · Cited by 86 · cited 1×
“Cerebral amyloid angiopathy (CAA), a cerebrovascular disorder characterized by the accumulation of A peptide in the tunica media and adventitia of cerebral blood vessels, is associated with vascular smooth muscle cell degeneration and loss of vessel wall integrity [45], resulting in impaired regulation of cerebral cir…”
BackgroundTian, J., Shi, J., Smallman, R., Iwatsubo, T., & Mann, D. M. A. (2006) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2006.00732.x · Cited by 61 · cited 2×
“The loss of vascular smooth muscle cells with disease progression weakens the vascular wall [127–129], increasing the susceptibility to abnormal vasodilatation and hemorrhage [126, 130, 131].”
BackgroundEndothelin-1 is Elevated in Alzheimer's Disease Brain Microvessels and is Neuroprotective
Luo, J., & Grammas, P. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-091486 · Cited by 39 · cited 1×
“Substantial evidence suggests that the upregulation of ET-1 observed in AD, both in the cerebral cortex [186, 190] and in cerebral blood vessels [191, 192], is caused by the accumulation of A [186, 187, 192–194].”
BackgroundPredominant endothelial vasomotor activity during human sleep: a near-infrared spectroscopy study
Zhang, Z., & Khatami, R. (2014) · European Journal of Neuroscience · doi:10.1111/ejn.12702 · Cited by 37
Princz-Kranz, F. L., Mueggler, T., Knobloch, M., Nitsch, R. M., & Rudin, M. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.06.002 · Cited by 28 · cited 1×
“In the former case, which is also supported by transgenic mouse studies [130], vessel dilation could reduce the vascular reactivity to vasodilatory stimuli such as ischemia [126, 132] or hypercapnia [133] (see section on cerebrovascular reactivity).”
Background
Cited by
Cerebrovascular Smooth Muscle Cells as the Drivers of Intramural Periarterial Drainage of the Brain
Aldea, R., Weller, R. O., Wilcock, D. M., Carare, R. O., & Richardson, G. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00001 · Cited by 332
Glymphatic solute transport does not require bulk flow
Asgari, M., de Zélicourt, D., & Kurtcuoglu, V. (2016) · Scientific Reports · doi:10.1038/srep38635 · Cited by 286
Liu, C.-C., Zhao, J., Fu, Y., Inoue, Y., Ren, Y., Chen, Y., Doss, S. V., Shue, F., Jeevaratnam, S., Bastea, L., et al. (2022) · Nature Neuroscience · doi:10.1038/s41593-022-01127-0 · Cited by 168
Blood-brain barrier leakage in Alzheimer’s disease: From discovery to clinical relevance
Nehra, G., Bauer, B., & Hartz, A. M. S. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108119 · Cited by 127
Reduced Cerebral Blood Flow in Mild Cognitive Impairment Assessed Using Phase-Contrast MRI
de Eulate, R. G., Goñi, I., Galiano, A., Vidorreta, M., Recio, M., Riverol, M., Zubieta, J. L., & Fernández-Seara, M. A. (2017) · Journal of Alzheimer’s Disease · doi:10.3233/jad-161222 · Cited by 48
Metadata
- Authors
- Di Marco, L. Y., Farkas, E., Martin, C., Venneri, A., & Frangi, A. F.
- Venue
- Journal of Alzheimer's Disease
- Publisher
- SAGE Publications
- Published
- 2015-05-07
- Volume
- 46
- Issue
- 1
- Pages
- 35-53
- ISSN
- 1387-2877 (ISSN-L)
- 1875-8908
- OpenAlex
- W179558530
- Cited by
- 95
- References
- 48
- FWCI
- 3.10
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.